Benzinga | Feb 25, 2021 05:08AM EST

KeyBanc Maintains Overweight on Teladoc Health, Raises Price Target to $270

KeyBanc analyst Donald Hooker maintains Teladoc Health (NYSE:TDOC) with a Overweight and raises the price target from $245 to $270.